235 related articles for article (PubMed ID: 20826787)
1. Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.
Amin AR; Wang D; Zhang H; Peng S; Shin HJ; Brandes JC; Tighiouart M; Khuri FR; Chen ZG; Shin DM
J Biol Chem; 2010 Nov; 285(45):34557-65. PubMed ID: 20826787
[TBL] [Abstract][Full Text] [Related]
2. Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth
Amin ARMR; Wang D; Nannapaneni S; Lamichhane R; Chen ZG; Shin DM
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33864659
[TBL] [Abstract][Full Text] [Related]
3. Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.
Amin AR; Khuri FR; Chen ZG; Shin DM
Cancer Prev Res (Phila); 2009 Jun; 2(6):538-45. PubMed ID: 19470788
[TBL] [Abstract][Full Text] [Related]
4. Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression.
Kang SU; Lee BS; Lee SH; Baek SJ; Shin YS; Kim CH
J Nutr Biochem; 2013 Jun; 24(6):986-99. PubMed ID: 23017582
[TBL] [Abstract][Full Text] [Related]
5. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
[TBL] [Abstract][Full Text] [Related]
6. Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2.
Haque A; Rahman MA; Chen ZG; Saba NF; Khuri FR; Shin DM; Ruhul Amin AR
Apoptosis; 2015 Jul; 20(7):986-95. PubMed ID: 25860284
[TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor.
Zhang X; Zhang H; Tighiouart M; Lee JE; Shin HJ; Khuri FR; Yang CS; Chen Z'; Shin DM
Int J Cancer; 2008 Sep; 123(5):1005-14. PubMed ID: 18546267
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation.
Roy AM; Baliga MS; Katiyar SK
Mol Cancer Ther; 2005 Jan; 4(1):81-90. PubMed ID: 15657356
[TBL] [Abstract][Full Text] [Related]
9. Grape seed extract induces anoikis and caspase-mediated apoptosis in human prostate carcinoma LNCaP cells: possible role of ataxia telangiectasia mutated-p53 activation.
Kaur M; Agarwal R; Agarwal C
Mol Cancer Ther; 2006 May; 5(5):1265-74. PubMed ID: 16731759
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and p53.
George J; Singh M; Srivastava AK; Bhui K; Roy P; Chaturvedi PK; Shukla Y
PLoS One; 2011; 6(8):e23395. PubMed ID: 21887248
[TBL] [Abstract][Full Text] [Related]
11. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma.
Nihal M; Ahmad N; Mukhtar H; Wood GS
Int J Cancer; 2005 Apr; 114(4):513-21. PubMed ID: 15609335
[TBL] [Abstract][Full Text] [Related]
12. Luteolin inhibits cell proliferation and induces cell apoptosis via down-regulation of mitochondrial membrane potential in esophageal carcinoma cells EC1 and KYSE450.
Chen P; Zhang JY; Sha BB; Ma YE; Hu T; Ma YC; Sun H; Shi JX; Dong ZM; Li P
Oncotarget; 2017 Apr; 8(16):27471-27480. PubMed ID: 28460467
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
Lee MH; Han DW; Hyon SH; Park JC
Apoptosis; 2011 Jan; 16(1):75-85. PubMed ID: 20963498
[TBL] [Abstract][Full Text] [Related]
14. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
Yamauchi R; Sasaki K; Yoshida K
Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
Lee SH; Nam HJ; Kang HJ; Kwon HW; Lim YC
Eur J Cancer; 2013 Oct; 49(15):3210-8. PubMed ID: 23876835
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer.
Shankar S; Suthakar G; Srivastava RK
Front Biosci; 2007 Sep; 12():5039-51. PubMed ID: 17569628
[TBL] [Abstract][Full Text] [Related]
17. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization.
Shi R; Huang Q; Zhu X; Ong YB; Zhao B; Lu J; Ong CN; Shen HM
Mol Cancer Ther; 2007 Apr; 6(4):1338-47. PubMed ID: 17431112
[TBL] [Abstract][Full Text] [Related]
18. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25.
Zan L; Chen Q; Zhang L; Li X
Bioengineered; 2019 Dec; 10(1):374-382. PubMed ID: 31431131
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
